Twitter Linkedin Envelope
REQUEST A CALL

Total Diversity Clinical Trial Management Launches New Book, Diversity In Clinical Trials Best Practices and Perspectives for Industry and Clinical Research Sites

Press Releases

/

November 29, 2022

(PRNewsfoto/Total Diversity)

(PRNewsfoto/Total Diversity)

DALLAS, Nov. 29, 2022 /PRNewswire/ — Total Diversity Clinical Trial Management (TOTAL), a global full-service Diversity Organization, has announced the launch of its new book, Diversity In Clinical Trials Best Practices and Perspectives for Industry and Clinical Research Sites. The text represents a compilation of evidence-based research and original articles by a variety of experts in the field of diversity in clinical trials.

The official launch took place at the Society of Clinical Research Sites (SCRS) Global Site Solutions Summit in Hollywood, Florida on October 8, 2022 with a personal signing session by the book’s co-authors Diana Foster, PhD, CEO and Chief Diversity Officer of TOTAL, and Vice Admiral Jerome Adams, MD, MPH, Chairman of the Board for TOTAL and Former 20th U.S. Surgeon General.

“We shouldn’t just look at new regulatory requirements as a box to be checked, but as an opportunity to improve outreach to, trust from, and health for marginalized and underserved populations. We hope this new book provides impetus to continue to marshal attention and action towards this critically important area”, Dr. Adams states.

In alignment with TOTAL’s mission of increasing and sustaining diversity in clinical trials and making a difference in quality of life for all individuals, this book is now internationally available on the Amazon Kindle Store in both eBook and paperback versions.

About TOTAL Diversity Clinical Trial Management

TOTAL Diversity Clinical Trial Management is a full-service CRO and Diversity Organization who has developed an operational, evidence-based delivery model to provide high quality, flexible, cost-effective patient engagement and diversity services to our Sponsor Companies. Service offerings directed at diversity include consulting, feasibility assessment for sites, training programs, patient recruitment and retention services and more. Our growing network of sites includes experienced diversity-oriented researchers as well as those who have access to diverse populations. www.totaldiversity.com

Amanda Rangel, MS
Senior Vice President, Business Development
Total Diversity Clinical Trial Management
[email protected]
+1-602-703-5288

View original content to download multimedia: https://www.prnewswire.com/news-releases/total-diversity-clinical-trial-management-launches-new-book-diversity-in-clinical-trials-best-practices-and-perspectives-for-industry-and-clinical-research-sites-301688186.html

SOURCE Total Diversity

REQUEST A CALL

Diana L. Foster, Ph.D

CEO and Chief Diversity Officer for TOTAL Diversity Clinical Trial Management

Diana L. Foster, Ph.D., is the CEO and Chief Diversity Officer for TOTAL Diversity Clinical Trial Management, a full-service Diversity Organization whose mission is to enhance diversity and inclusion in clinical research trials. Foster has served as the Vice President of Diversity, Equity, and Inclusion for the Society of Clinical Research Sites (SCRS) since 2016. She also held a position as the Vice President of Strategy and Development for SCRS originating programs such as the Global Impact Partner Programs and many other industry supported initiatives.

Foster is a thought-leader and sought-after expert in diversity and clinical site best practices. She is the author of the Diversity Site Assessment Tool and has published numerous research papers on the topic. Over the past two decades, she has addressed audiences across the world, published multiple papers and articles, and written five authoritative industry books including Global Issues in Patient Recruitment and Retention.

Jerome Adams, M.D.

Chairman of the Board for TOTAL Diversity Clinical Trial Management

Dr. Adams also currently serves as Executive Director of Health Equity Initiatives at Purdue University. He formerly served as the 20th United States Surgeon General and as a member of the President’s COVID-19 task force, where he was at the forefront of America’s most pressing health challenges throughout the pandemic, including working with companies to increase diversity in vaccine trials.

As the Chairman of the Board for TOTAL Diversity, Dr. Adams provides his in-depth knowledge of patient perspectives and industry views on diversity to create sustainable solutions and best practices to establish more diverse representation in clinical trials.